- BioHarvest Sciences (BHSC) has successfully produced 10 kilograms of full-spectrum cannabis biomass at a commercial scale
- The biomass is produced without growing the plant itself and solves the problems of product variability and product contamination in cannabis production
- BioHarvest believes this result is a win for global sustainability
- BioHarvest Sciences is a biotechnology company
- Shares in BioHarvest Sciences Inc. (BHSC) are up 11.11 per cent, trading at $0.40 per share
BioHarvest Sciences (BHSC) has successfully produced 10 kilograms of full-spectrum cannabis biomass at a commercial scale.
Produced without growing the plant itself, the cannabis biomass has a density of Trichome cells of up to 200 times greater than in a plant-grown product.
The breakthrough solves two major setbacks when it comes to product quality in the medicinal cannabis industry: product variability and product contamination.
The result, believes BioHarvest, is a win for global sustainability, which the company says will usher in a new era by conserving land not just from cannabis cultivation but from other plants as well.
The cannabis biomass is not genetically modified and was produced using the company’s proprietary BioFarming technology platform, which grows plant cells in their natural structure in proprietary bioreactors.
The company has already used this technology to produce red grapes, olives, and pomegranates, and uses the artificially grown red grapes to produce its VINIA brand.
“This major scientific and technological achievement is unprecedented in the cannabis world and is a strong validation of the superiority of the BioFarming technology,” said BioHarvest CTO Yochi Hagay.
The cannabis biomass produced by BioHarvest’s technology has significant advantages compared to cannabis produced through conventional cultivation, summed up by what the company refers to as the 5 Cs: Consistency, cleanliness, cost, composition, and climate.
“The legal cannabis industry has been waiting for this moment as many of the challenges it has faced are being resolved using BioHarvest’s technology and capabilities,” said BioHarvest CEO Ilan Sobel.
“With this milestone,” he added, “we are ready to start engaging with key players in the global cannabis industry for the right partnerships ahead of the introduction of our new cannabis products.”
BioHarvest also announced that it has appointed astronaut Chris Hadfield to its advisory board as the company works to leverage its biotechnology platform for the challenges of space exploration.